Patent · US Revoked

Method and composition for treating rhinitis

US9839633B2 · kind B2 · utility

0Cited by

11References

3Claims

0Family size

Assignee

Biolipox AB · SE

Inventors

Lena Pereswetoff-Morath · Spånga, SE
Anders Carlsson · Lund, SE

Key dates

Filing date	Apr 11, 2012
Grant date	Dec 12, 2017
Priority date	—
Expiry date	Oct 18, 2034

Classification

Technology area (CPC —)General

Abstract

There is provided pharmaceutical compositions for the treatment of rhinitis by, for example, nasal or ocular administration comprising zwitterionic cetirizine, a polar lipid liposome and a pharmaceutical acceptable aqueous carrier. The compositions are preferably homogeneous in their nature.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.